Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9846955 | 0.95 | KDM4E (0.32) | KDM4ETSHRTDP1 | |
| Silver SCHEMBL27028187 | 0.95 | KDM4E (0.32) | KDM4ETSHRTDP1 | |
| Lithium Ion SCHEMBL28440605 | 0.80 | KDM4E (0.39) | KDM4ETSHRTDP1 | |
| SCHEMBL16034568 | 0.80 | KDM4E (0.39) | KDM4ETSHRTDP1 | |
| SCHEMBL5066665 | 0.77 | TSHR (0.36) | KDM4ETSHRTDP1 | |
| Lithium Ion SCHEMBL5069418 | 0.77 | TSHR (0.36) | KDM4ETSHRTDP1 | |
| SCHEMBL5066670 | 0.77 | TSHR (0.36) | KDM4ETSHRTDP1 | |
| Lithium Ion SCHEMBL5070255 | 0.77 | TSHR (0.36) | KDM4ETSHRTDP1 | |
| Potassium Ion SCHEMBL5066767 | 0.77 | TSHR (0.36) | KDM4ETSHRTDP1 | |
| Potassium Ion SCHEMBL5066663 | 0.77 | TSHR (0.36) | KDM4ETSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040214881-A1 | Method for producing optically active halopropanediol derivative | KANEKA CORPORATION (JP) | 2004-10-28 | — | — | US | disclosed |
| EP-1422213-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE HALOPROPANEDIOL DERIVATIVE | KANEKA CORPORATION (JP) | 2004-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214881-A1 | Method for producing optically active halopropanediol derivative | HPD, ADH1A, ADH5 | KDM4E 4029/4885TSHR 1955/4885TDP1 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.